Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster ...

Jyong Biotech Ltd. (Nasdaq:MENS), a biotechnology company centered on scientific development of botanical drug therapies, has marked its official listing on the Nasdaq Composite.

Halfway into 2025, the capital raised in U.S.-listed IPOs has already reached 73% of 2024's full-year volume, according to ...

Graphjet Technology Faces Nasdaq Listing Compliance Issues, Plans Hearing Request June 10, 2025 — 04:41 pm EDT Written by None for Quiver Quantitative -> ...

AGM Holdings received Nasdaq approval for continued listing, contingent on meeting certain compliance requirements by June 2025. Quiver AI Summary AGM Group Holdings Inc. has announced that the ...

As previously reported by Greenlane on its current report on Form 8-K, on April 2, 2025, the Listing Qualifications Department (the "Nasdaq Staff") of the Nasdaq Stock Market ("Nasdaq") issued a ...

BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories ...

The company is now in good standing with Nasdaq Capital Market’s listing requirements following the filing of its unaudited financial statements for the six-month periods ending November 30 ...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4)WILMINGTON, Del.-- (BUSINESS WIRE)-- Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs ...

BOCA RATON, FL / ACCESS Newswire / June 2, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories ...

Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on June 2, 2025, the Compensation Committee of the ...

REDWOOD CITY, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted ...